Smith, Kathleen J <br/><br/>
Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors.  [electronic resource] 

 -  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]  Nov 2009 
 - 1766-70 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1524-4725 
<br/><br/><label>Standard No.: </label>10.1111/j.1524-4725.2009.01289.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Benzenesulfonates--adverse effects<br/>Carcinoma, Squamous Cell--chemically induced<br/>Female<br/>Humans<br/>Keratoacanthoma--chemically induced<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--chemically induced<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Protein Kinase Inhibitors--adverse effects<br/>Pyridines--adverse effects<br/>Skin Neoplasms--chemically induced<br/>Sorafenib